Free Trial

Hotchkis & Wiley Capital Management LLC Cuts Stock Holdings in Proto Labs, Inc. $PRLB

Proto Labs logo with Industrials background

Key Points

  • Hotchkis & Wiley Capital Management LLC reduced its stake in Proto Labs, Inc. by 53.2%, selling 173,020 shares, and now owns 152,100 shares valued at approximately $5.33 million.
  • Proto Labs reported $0.41 earnings per share (EPS) for the last quarter, exceeding estimates and showing a 7.6% year-over-year revenue increase to $135.06 million.
  • Several analysts have upgraded Proto Labs, with a consensus rating of "Moderate Buy" and a price target averaging $52.50, indicating positive market sentiment.
  • Want stock alerts on Proto Labs? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Hotchkis & Wiley Capital Management LLC cut its stake in Proto Labs, Inc. (NYSE:PRLB - Free Report) by 53.2% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 152,100 shares of the industrial products company's stock after selling 173,020 shares during the period. Hotchkis & Wiley Capital Management LLC owned 0.64% of Proto Labs worth $5,330,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. GAMMA Investing LLC boosted its stake in Proto Labs by 249.4% in the 1st quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company's stock worth $32,000 after purchasing an additional 661 shares in the last quarter. Victory Capital Management Inc. acquired a new stake in Proto Labs in the 1st quarter worth approximately $584,000. CWM LLC boosted its stake in Proto Labs by 50.4% in the 1st quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock worth $64,000 after purchasing an additional 617 shares in the last quarter. Bank of America Corp DE boosted its stake in Proto Labs by 109.1% in the 4th quarter. Bank of America Corp DE now owns 54,447 shares of the industrial products company's stock worth $2,128,000 after purchasing an additional 28,407 shares in the last quarter. Finally, Aquatic Capital Management LLC boosted its stake in Proto Labs by 18.2% in the 4th quarter. Aquatic Capital Management LLC now owns 8,981 shares of the industrial products company's stock worth $351,000 after purchasing an additional 1,381 shares in the last quarter. 84.54% of the stock is currently owned by institutional investors and hedge funds.

Proto Labs Trading Down 0.3%

NYSE PRLB traded down $0.13 on Thursday, hitting $50.71. 163,456 shares of the company's stock traded hands, compared to its average volume of 204,258. Proto Labs, Inc. has a 1-year low of $26.34 and a 1-year high of $51.09. The firm's 50-day moving average price is $43.06 and its two-hundred day moving average price is $39.49. The firm has a market capitalization of $1.21 billion, a PE ratio of 84.52 and a beta of 1.33.

Proto Labs (NYSE:PRLB - Get Free Report) last posted its earnings results on Thursday, July 31st. The industrial products company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.08. The firm had revenue of $135.06 million during the quarter, compared to analyst estimates of $128.05 million. Proto Labs had a net margin of 2.91% and a return on equity of 2.22%. The business's quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.38 EPS. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. On average, research analysts anticipate that Proto Labs, Inc. will post 0.81 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

PRLB has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of Proto Labs from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. Cantor Fitzgerald lifted their price objective on shares of Proto Labs from $50.00 to $51.00 and gave the company an "overweight" rating in a research note on Friday, August 1st. Finally, Craig Hallum upgraded shares of Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price objective for the company in a research note on Friday, August 1st. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $52.50.

Read Our Latest Report on Proto Labs

Insider Buying and Selling at Proto Labs

In other news, CEO Suresh Krishna bought 1,725 shares of the business's stock in a transaction dated Monday, August 4th. The stock was purchased at an average cost of $43.51 per share, with a total value of $75,054.75. Following the acquisition, the chief executive officer directly owned 18,021 shares in the company, valued at $784,093.71. This trade represents a 10.59% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.70% of the stock is currently owned by company insiders.

Proto Labs Profile

(Free Report)

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.

See Also

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Should You Invest $1,000 in Proto Labs Right Now?

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines